ПРЕДВАРИТЕЛЬНЫЕ РЕЗУЛЬТАТЫ ИСПОЛЬЗОВАНИЯ ПРЕДОПЕРАЦИОННОЙ ХИМИОТЕРАПИИ В ЛЕЧЕНИИ НИЗКОДИФФЕРЕНЦИРОВАННОЙ АДЕНОКАРЦИНОМЫ ЖЕЛУДКА
Голодников Михаил Андреевич, Зубков Роман Александрович, Дворниченко Виктория Владимировна et al. · Сибирский медицинский журнал (Иркутск) · 2014
Purpose — study of the effect of preoperative chemotherapy on survival of patients with gastric cancer who underwent radical surgery. We corrected the analysis of case histories and outpatient cards of 772 patients with gastric cancer, who was treated in Regional oncological clinic from 2000 to 2012. Inclusion criteria were: 1) low-grade adenocarcinoma of stomach 2) radical operation. Exclusion criterions were: 1) another oncologic disease 2) distal resection of stomach in anamnesis 3) IV stage of tumor 4) age over 55 years. We selected 150 patients who were divided into two groups. In the first group (n=78) treatment was started with operation, in the second group (n=72) treatment was started with a chemotherapy. The groups were comparable on sex, age, on distribution of stages of tumoral process and volume of operations. Average time of observation in the first group amounted to 43,2±27,4 months, a median — 37,6 months, in the second — 57±28,7 months, a median — 61,3 months. The one-year survival in the first and second group amounted to 90,9±3,3% and 97,2±1,9% (P=0,17), and three-year69,7±5,5% and 85,5±4,2% respectively (P=0,023). At present the median of survival in the groups has not been reached. We used to compare survival curves in groups on the criterion of Gehan-Wilcoxon P=0,037. In the group of patients with preoperative chemotherapy, the survival was higher. The use of preoperative chemotherapy allows to improve indicators of survival of patients with immature adenocarcinoma of stomach in age group till 55 years
Cited by 0 works. doi:10.1234/xxxx-xxxx-2014-6-52-55